• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SNPに対するジーンチップによる肺癌EGFR変異遺伝子関連遺伝子の発見とその解析

Research Project

Project/Area Number 19590924
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionMiyagi Cancer Center Research Institute

Principal Investigator

マエモンド マコト  Miyagi Cancer Center Research Institute (40344676)

Co-Investigator(Renkei-kenkyūsha) ハギワラ コウイチ   (00240705)
Project Period (FY) 2007 – 2008
Project Status Completed (Fiscal Year 2008)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2008: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2007: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywords非閉塞性肺疾患癌 / 肺線維症 / 呼吸器感染症 / その他・肺癌 / EGFR遺伝子変異 / 癌 / 遺伝子
Research Abstract

Lung cancer is a major cause of cancer death, and one of the most resistant cancers to treatment. Several mutations in the lung tumor were found so far, which were studied in terms of the association with oncogenicity, targets of therapy. It was demonstrated that epidermal growth factor receptor (EGFR) mutation in tumor cells exists among the lung cancer patients but not among other organ type of cancer. Gefitinib is an orally administered tyrosine kinase inhibitor (TKI) of EGFR that was approved in Japan for the first time in the world. This drug has substantial role on treatment with non-small cell lung cancer patients, especially has characteristics that include female, never smoker, and adenocarcinoma histology. The response of treatment with gefitinib was found strongly correlated with both these patients characteristics and EGFR mutations. In addition, it was reported that there are more EGFR mutations in tumor cells of Asians than in Westerners. On the hypotheses of that there are associate genes with this ethnic difference in incidence of mutation in the tumor cells, we conducted the study to identify these associated genes by the analysis of SNP through the whole genome with Gene chip assay.

Report

(3 results)
  • 2008 Annual Research Report   Final Research Report ( PDF )
  • 2007 Annual Research Report
  • Research Products

    (5 results)

All 2008 2007

All Journal Article (5 results) (of which Peer Reviewed: 1 results)

  • [Journal Article] Randomized phase 11 trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer : North japan lung Cancer : Study Group Trial 04022008

    • Author(s)
      Inoue A, Sugawara S, Yamazaki
    • Journal Title

      J Clin Oncol 26

      Pages: 5401-5406

    • Related Report
      2008 Final Research Report
  • [Journal Article] Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation2008

    • Author(s)
      Inoue A, Xin H, Suzuki T
    • Journal Title

      Cancer Sci 99

      Pages: 1679-1684

    • Related Report
      2008 Final Research Report
  • [Journal Article] Rendomized phase 11 trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer : North japan lung Cancer Study Group Trial 04022008

    • Author(s)
      Inoue A, Sugawara S, Yamazaki k
    • Journal Title

      J Clin Oncol 26(33)

      Pages: 5401-6

    • Related Report
      2008 Annual Research Report
  • [Journal Article] Suppression of surfactant protein A by an epidermal growth factor receptor tyrosine kinase inhibitor exacerbates lung inflammation2008

    • Author(s)
      Inoue A, Xin H, Suzuki T
    • Journal Title

      Cancer Sci 99(8)

      Pages: 1679-84

    • Related Report
      2008 Annual Research Report
  • [Journal Article] Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells2007

    • Author(s)
      Kanehira M, Xin H, Hoshino K
    • Journal Title

      Cancer Gene Ther. 14

      Pages: 894-903

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed

URL: 

Published: 2007-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi